Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 211 - Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
Patents for C07D 211 - Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings (37,939)
12/2005
12/08/2005US20050272793 Pyrazole compounds and uses related thereto
12/08/2005US20050272775 Polymorph of (1-benzyl-4-[(5,6-dimethoxy-1-indanone)-2-y1] methyl piperidine hydrochloride (Donepezil hydrochloride) and a process for producing thereof
12/08/2005US20050272774 Substituted cyclohexane derivatives
12/08/2005US20050272771 Such as terfenadine carboxylic acid metabolite and carebastine using a 4-(4-halo-1-oxobutyl)-alpha,alpha-dimethyl-alpha-substituted toluene intermediate
12/08/2005US20050272751 Inhibitors of Rho kinase; N-Benzyloxycarbonyl-4-[N''-(tert-butyloxycarbonyl)hydrazino]piperidine; 4-{[N''-(tert-butyloxycarbonyl)-N'-(1'-propyl)]hydrazino}piperidine
12/08/2005US20050272745 Novel piperidine and piperazine derivatives
12/08/2005US20050272744 N-((4-((( 1R)-3 -(dimethylamino)-1-((phenylsulfanyl)methyl)propyl)amino)-3-nitrophenyl)sulfonyl)-4-(4-(2-fluorobenzyl)-4-methoxy-1-piperidinyl)benzenecarboximidamide; trigger apoptosis through the inhibition of the Bcl family of proteins
12/08/2005US20050272036 Ketones
12/08/2005US20050271736 Hydroxy-, amino-, and mercapto-substituted 1-oxydihydropyridine-2-thiones; and adducts with polyvalent isocyanates, which when polymerized form microcapsule walls; for use in industrial bactericides; chemical resistance
12/08/2005DE102004023640A1 Verfahren zur Herstellung von 4-substituierten 2,2,6,6-Tetramethyl-piperidin-N-oxy- und 2,2,6,6-Tetramethyl-piperidin-N-hydroxy-verbindungen Process for the preparation of 4-substituted 2,2,6,6-tetramethyl-piperidine-N-oxy and 2,2,6,6-tetramethyl-piperidine-N-hydroxy compounds
12/08/2005CA2568050A1 Indazole and indolone derivatives and their use as pharmaceuticals
12/08/2005CA2566942A1 Androgen receptor modulators and method of treating disease using the same
12/08/2005CA2565066A1 Therapeutic compounds
12/08/2005CA2564884A1 Cyclohexylalanine derivatives as dipeptidyl peptidase-iv inhibitors for the treatment or prevention of diabetes
12/08/2005CA2564638A1 Aryl sulfonamide and sulfonyl compounds as modulators of ppar and methods of treating metabolic disorders
12/08/2005CA2509311A1 Fexofenadine polymorphs and process for the preparation thereof
12/07/2005EP1602645A1 Nitrogenous heterocyclic derivative having 2,6-disubstituted styryl
12/07/2005EP1602642A1 Imino ether derivative compounds and drugs containing the compounds as the active ingredient
12/07/2005EP1602368A2 Cdc25 phosphatase inhibitors
12/07/2005EP1601643A1 Arylcycloalkyl derivatives with branched side chains as ppar receptor modulators, method for their production and their use as medicaments
12/07/2005EP1467984A4 Synthesis of 4,5-dihydro-pyrazolo (3,4-c) pyrid-2-ones
12/07/2005EP1307449B1 1,4-dihydropyridines as bradykinin antagonists
12/07/2005CN1705660A New dihydro-4(1h)-pyridinone derivatives are useful in the treatment of cognitive disorders, neurodegenerative diseases and pain
12/07/2005CN1705644A Novel piperidine derivatives and their use as monoamine neurotransmitter re-uptake inhibitors
12/07/2005CN1705635A Inhibitors of histone deacetylase
12/07/2005CN1704406A Intermediate for the preparation of epimino
12/07/2005CN1704402A Antibacterial agents
12/07/2005CN1230554C Method for enzymatic enantiomer-separation of 3(R)-and 3(S)-hydroxy-1-methyl-4-(2,4,6-trimethoxyphenyl)-1,2,3,6-tetrahydro-pyridine or its carboxylic acid esters
12/07/2005CN1230431C Arylmethylamine derivatives for use as tryptase inhibitors
12/07/2005CN1230424C Hydroxy substituted N-alkoxy hindered amine
12/06/2005US6972340 For therapy of diabetes, obesity, autoimmune disorders, acute and chronic inflammatory disorders, osteoporosis, cancer, malignant disorders
12/06/2005US6972296 Antichoelsterol agents; cardiovascular disorders; antihistamines; multiple sclerosis; antihistamines
12/06/2005US6972295 Central nervous system disorders; psychological disorders; antiinflammatory agents; multiple sclerosis
12/06/2005CA2325282C Use of apo b secretion/mtp inhibitors
12/06/2005CA2268866C Substituted arylalkylamines as neurokinin antagonists
12/06/2005CA2206787C 2,5-diamino-3,4-disubstituted-1,6-diphenylhexane isosteres comprising benzamide, sulfonamide and anthranilamide subunits and methods of using same
12/06/2005CA2096528C Retroviral protease inhibitors
12/01/2005WO2005113527A1 Tetrahydronaphthyl- piperazines as 5-ht1b antagonists, inverse agonists and partial agonists
12/01/2005WO2005113504A1 Cyclic amide derivatives, and their production and use as antithrombotic agents
12/01/2005WO2005113503A2 Metabolites of (+)-(2s, 3s)-3-(2-methoxy-5-trifluoromethoxybenzylamino)-2-phenyl-piperidine
12/01/2005WO2005112945A2 Synthesis of tetracyclines and analogues thereof
12/01/2005WO2005077899A3 Amino-substituted tricyclic derivatives and methods of use
12/01/2005WO2005060603A3 Nitric oxide releasing pyruvate compounds, compositions and methods of use
12/01/2005US20050267173 Serine protease inhibitors
12/01/2005US20050267169 Watersoluble prodrugs of propofol
12/01/2005US20050267153 Administering N-substituted-1,5-dideoxy-1,5-imino-D-glucitol compounds alone or in combination with nucleoside antiviral agents, nucleotide antiviral agents, mixtures thereof, or immunomodulating/immunostimulating agents; inhibiting replication and secretion, reduced toxicity
12/01/2005US20050267152 Gly1 transporter inhibitors and uses thereof in treatment of neurological and neuropsychiatric disorders
12/01/2005US20050267129 Dipeptide nitrile cathepsin K inhibitors
12/01/2005US20050267126 Compounds derived from aryl carbamates, preparation thereof and uses of same
12/01/2005US20050267123 6-Membered heterocyclic compounds useful for selective inhibition of the coagulation cascade
12/01/2005US20050267118 Inhibitors of factor Xa and other serine proteases involved in the coagulation cascade
12/01/2005US20050265961 Biodegradable poly(beta-amino esters) and uses thereof
12/01/2005CA2567506A1 Cyclic amide derivatives, and their production and use as antithrombotic agents
12/01/2005CA2566934A1 Tetrahydronaphthyl- piperazines as 5-ht1b antagonists, inverse agonists and partial agonists
12/01/2005CA2566920A1 Metabolites of (+)-(2s, 3s)-3-(2-methoxy-5-trifluoromethoxybenzylamino)-2-phenyl-piperidine
11/2005
11/30/2005EP1600441A2 Novel crystalline form of lercanidipin hydrochloride and processes for its preparation
11/30/2005EP1599447A1 Ligands that modulate lxr-type receptors
11/30/2005EP1363882A4 3-(3-amidinophenyl)-5- ( 1-(1-(-iminoethyl)-4-piperidyl amino)methyl]benzoic acid dihydrochloride and process for preparing the same
11/30/2005EP1274457B1 Method and compositions for the treatment of allergic conditions using pgd2 receptor antagonists
11/30/2005EP1098864B9 Method for hydrogenating unsaturated heterocyclic compounds
11/30/2005EP0963200B9 Compositions for inhibition of angiogenesis comprising thalodomide and a nsaid
11/30/2005CN1703411A Piperidine derivatives as CCR5 inhibitors
11/30/2005CN1703401A Melanin concentrating hormone receptor ligands: substituted 1-benzyl-4-aryl piperazine analogues
11/30/2005CN1703400A Substituted 1,4-di-piperidin-4-yl-piperazine derivatives and their use as neurokinin antagonists
11/30/2005CN1703395A Aryl and heteroaryl compounds and methods to modulate coagulation
11/30/2005CN1703393A Spiro compounds, medicinal compositions containing the same and intermediates of the compounds
11/30/2005CN1229396C Catalytic system
11/30/2005CN1229377C Spiro [Piperidine-4,1'-pyrrolo[3,4-c] pyrrole]
11/30/2005CN1229373C Piperidinee derivatives as neurokinin1 antagonists
11/30/2005CN1229348C Method for preparing amlodipine
11/30/2005CN1229347C Process for production of piperidine derivative fexofenadine
11/30/2005CN1229346C Diastereomer salts of terfenadine
11/30/2005CN1229343C Chemotactic factor receptor active regulator
11/30/2005CN1229335C Nervinolin derivatives
11/29/2005US6969768 Preparation of 4-haloalkylnicotinic esters
11/29/2005US6969724 Compounds
11/29/2005US6969718 17-β hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases
11/29/2005US6969715 6-membered heterocyclic compounds useful for selective inhibition of the coagulation cascade
11/29/2005US6969713 Piperidine and piperazine acetamide derivatives
11/29/2005CA2355493C Therapeutic compositions comprising excess enantiomer
11/24/2005WO2005110992A1 Amido compounds and their use as pharmaceuticals
11/24/2005WO2005110988A1 Pyridone compounds as inhibitors of bacterial type iii protein secretion systems
11/24/2005WO2005110987A1 Piperidine derivatives as nk1 and nk3 antagonists
11/24/2005WO2005110984A1 Process for producing cyclic n-hydroxyimide compound
11/24/2005WO2005092011A3 Mitotic kinesin inhibitors
11/24/2005WO2005090296A3 N-substituted benzene sulfonamides
11/24/2005WO2005077884A3 Hydroaminomethylation of olefins
11/24/2005WO2005041875A3 Dopamine-, norepinephrine- and serotonin- transporter- selective heterocyclic compounds and their therapeutic applications
11/24/2005WO2004113297A9 Aza-ring derivatives and their use as monoamine neurotransmitter re-uptake inhibitors
11/24/2005US20050261496 3-(Morpholin-4-ylsulfonyl)-5-(1,3-thiazol-2-yl)-1H-indole-2-carboxamide; inhibiting, modulating and/or regulating signal transduction of both receptor and non-receptor tyrosine kinases; anticarcinogenic, -diabetic, -arhtritic, -inflammatory agents; psoriasis; angiogenesisinhibitors; liver cirrhosis
11/24/2005US20050261401 for stabilizing aqueous polymer systems (water borne coatings, aqueous inks, aqueous ink jet media, and photocured aqueous systems) against oxidative, thermal and actinic radiation
11/24/2005US20050261343 Anthranilamides and their use as pharmaceutical agents
11/24/2005US20050261342 Metabolites of (+)-(2S,3S)-3(2-methoxy-5- trifluoromethoxybenzylamino)-2-phenyl-piperidine
11/24/2005US20050261341 reacting (R)-alpha-(2,3-dimethoxyphenyl)-4-piperidinemethanol with 4-fluorophenylethyl alkylating agent
11/24/2005US20050261325 Gamma-aminoamide modulators of chemokine receptor activity
11/24/2005US20050261293 Compounds which inhibit leukocyte adhesion mediated by VLA-4
11/24/2005US20050261291 1-Cyclopropylmethyl-4-[2-(3,3,5,5-tetramethylcyclohexyl)phenyl]piperazine or a salt or hydrate; exhibit excellent cell adhesion inhibitory action or cell infiltration inhibitory action; for treating inflammatory diseases and autoimmune diseases such as inflammatory bowel diseases and rheumatoid arthritis
11/24/2005US20050261290 Novel compounds of proline and morpholine derivatives
11/24/2005US20050261287 Lactam-containing compounds and derivatives thereof as factor Xa inhibitors
11/24/2005US20050261276 Novel sulphones for inhibition of gamma secretase
1 ... 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 ... 380